FDA Warns Against Detoxi Slim Due to Hidden Sibutramine Ingredient
The Food and Drug Administration (FDA) continues to advise consumers against purchasing or using Detoxi Slim, a weight loss product sold by People’s Bazaar II and potentially available in various retail stores and online. Recent laboratory tests conducted by the FDA confirmed that Detoxi Slim contains sibutramine, a substance not listed on the product's label. Sibutramine was removed from the market in October 2010 due to safety concerns, as it is known to significantly increase blood pressure and heart rate in some individuals. This poses a considerable risk, especially for those with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Additionally, sibutramine may interact dangerously with other medications that consumers might be taking.
The FDA's notification highlights a concerning trend in the dietary supplement market, where products are often marketed as 'all natural' while containing harmful hidden ingredients. These products are typically promoted for weight loss, sexual enhancement, or bodybuilding. The FDA has noted that it cannot test every dietary supplement for potentially dangerous hidden substances, urging consumers to exercise caution when considering products in these categories. Health care professionals and patients are encouraged to report any adverse events or side effects related to the use of Detoxi Slim to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. This ongoing vigilance is essential to protect public health and ensure consumer safety in the face of misleading product claims.




